| Carolyn Green, CNM | |
|
101 Bethesda Dr, Greenville, NC 27834-7201 | |
| (252) 758-4181 | |
| (252) 758-2603 |
| Full Name | Carolyn Green |
|---|---|
| Gender | Female |
| Speciality | Advanced Practice Midwife |
| Location | 101 Bethesda Dr, Greenville, North Carolina |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1104874296 | NPI | - | NPPES |
| 7002041 | Medicaid | NC |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367A00000X | Advanced Practice Midwife | 11550 (North Carolina) | Primary |
| Entity Name | Physicians East Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1598761967 PECOS PAC ID: 1850284571 Enrollment ID: O20040205001222 |
News Archive
Cohesins are protein complexes that join the two copies of each chromosome-called sister chromatids-to ensure that they are shared fairly between the daughter cells during cell division. In this way, each daughter cell receives exactly the same genetic information from the parent cell.
For the first time, scientists at Albert Einstein College of Medicine have developed a technology allowing them to "see" single molecules of messenger RNA as they are translated into proteins in living mammalian cells. Initial findings using this technology that may shed light on neurological diseases as well as cancer were published online today in Science.
A drug commonly used to treat pain, epilepsy, anxiety and other brain health disorders may be associated with an increased risk of major birth defects, according to a study published in the May 18, 2016, online issue of Neurology, the medical journal of the American Academy of Neurology.
BioWa, Inc. announced today that it has entered into two agreements with GlaxoSmithKline. BioWa and GSK have amended their existing 2007 arrangement in order to provide GSK with extended access to BioWa's POTELLIGENT Technology platform for the research, development and commercialization of their antibody therapeutics with enhanced antibody-dependent cellular cytotoxicity. The second license agreement provides GSK with access to BioWa's COMPLEGENT Technology for enhancing the complement-dependent cytotoxicity of select GSK therapeutic antibodies.
PROLOR Biotech, Inc., a company developing next generation biobetter therapeutic proteins, today announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation to hGH-CTP, PROLOR's longer-acting version of human growth hormone for the treatment of growth hormone deficiency.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Carolyn Green, CNM 1850 W Arlington Blvd, Greenville, NC 27834-5704 Ph: (252) 752-6101 | Carolyn Green, CNM 101 Bethesda Dr, Greenville, NC 27834-7201 Ph: (252) 758-4181 |
News Archive
Cohesins are protein complexes that join the two copies of each chromosome-called sister chromatids-to ensure that they are shared fairly between the daughter cells during cell division. In this way, each daughter cell receives exactly the same genetic information from the parent cell.
For the first time, scientists at Albert Einstein College of Medicine have developed a technology allowing them to "see" single molecules of messenger RNA as they are translated into proteins in living mammalian cells. Initial findings using this technology that may shed light on neurological diseases as well as cancer were published online today in Science.
A drug commonly used to treat pain, epilepsy, anxiety and other brain health disorders may be associated with an increased risk of major birth defects, according to a study published in the May 18, 2016, online issue of Neurology, the medical journal of the American Academy of Neurology.
BioWa, Inc. announced today that it has entered into two agreements with GlaxoSmithKline. BioWa and GSK have amended their existing 2007 arrangement in order to provide GSK with extended access to BioWa's POTELLIGENT Technology platform for the research, development and commercialization of their antibody therapeutics with enhanced antibody-dependent cellular cytotoxicity. The second license agreement provides GSK with access to BioWa's COMPLEGENT Technology for enhancing the complement-dependent cytotoxicity of select GSK therapeutic antibodies.
PROLOR Biotech, Inc., a company developing next generation biobetter therapeutic proteins, today announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation to hGH-CTP, PROLOR's longer-acting version of human growth hormone for the treatment of growth hormone deficiency.
› Verified 2 days ago
Jennifer Lynn Perry-hidalgo, CNM Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 201 Government Cir, Greenville, NC 27834 Phone: 252-902-2300 | |
Mrs. Tess Eden Garland, CNM Advanced Practice Midwife Medicare: Not Enrolled in Medicare Practice Location: 2251 Stantonsburg Rd, Greenville, NC 27834 Phone: 252-757-3131 Fax: 252-757-9600 | |
Margaret Reither, CNM Advanced Practice Midwife Medicare: Accepting Medicare Assignments Practice Location: 2160 Herbert Ct, Greenville, NC 27834 Phone: 252-744-3850 Fax: 252-744-3894 | |
Anne Catherine Scott Barnes, Advanced Practice Midwife Medicare: Not Enrolled in Medicare Practice Location: 600 Moye Blvd, Greenville, NC 27834 Phone: 252-744-6478 | |
Mrs. Renee Oakley Spain, CNM Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: East Carolina University School Of Nursing, Nurs-allied Hlth Bldg, West Campus, Greenville, NC 27834 Phone: 252-744-0000 | |
Maghan Wooten, Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 101 Bethesda Dr, Greenville, NC 27834 Phone: 252-748-4181 |